IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2007;48:4890-4896.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-0215
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meir, T.
Right arrow Articles by Chowers, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meir, T.
Right arrow Articles by Chowers, I.

Molecular Characteristics of Liver Metastases from Uveal Melanoma

Tal Meir,1,2 Rinat Dror,1,2 Xueping Yu,3 Jiang Qian,3 Itamar Simon,4 Jacob Pe’er,1 and Itay Chowers1

1From the Department of Ophthalmology, Hadassah Hebrew University Medical Center, Jerusalem, Israel; The 3Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; and the 4Department of Molecular Biology, Hebrew University Faculty of Medicine, Jerusalem, Israel.

PURPOSE. The liver is the most common site of systemic metastases from uveal melanoma (UM). Such metastases usually continue to develop despite the application of current treatment modalities. This study was conducted to obtain insight into the molecular pathways that underlie the development of UM metastasis and thus to identify potential novel therapeutic pathways for this disease.

METHODS. Microarray analysis of seven primary UMs and seven liver metastases from UMs was performed by using oligonucleotide microarrays containing 35,035 features. Bioinformatics was applied to identify expression patterns associated with metastases. Results were validated with real-time quantitative RT-PCR (QPCR) and immunohistochemistry (IHC).

RESULTS. Metastasis-associated expression was detected for 193 genes at the false discovery rate (FDR) level of 0%. QPCR confirmed microarray results for all 11 genes that were evaluated (r2 = 0.9, P = 0.0001), and IHC validated microarray data for the two proteins (NFKB2 and CDK4) that were assessed. The gene expression pattern of UM liver metastases demonstrated a resemblance to normal liver tissue. Bioinformatics facilitate identification of transcription factors, among them NFKB, which potentially regulate expression of several metastasis-associated genes.

CONCLUSIONS. Liver metastases from UMs have a distinct gene expression pattern compared with the primary tumor while sharing similarities with gene expression patterns of normal liver. Several candidate genes for involvement in UM metastasis have been identified—among them several in the NFKB pathway.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology